As many as 44 companies that were set to raise over ₹66,000 crore after getting approvals from markets regulator Sebi have temporarily paused their IPOs, as per Prime Database, a capital markets data ...

Biopharmaceutical initial public offerings (IPOs) saw an upturn in 2024, with 50 completed IPOs raising a total of $8.52 ...

We recently published a list of the 12 Best IPO Stocks to Buy in 2025. In this article, we are going to take a look at where CG Oncology, Inc. (NASDAQ:CGON) stands against other best IPO stocks to buy ...

Despite a recent pause in the primary market amid volatility in the secondary market, initial public offering (IPO) ...

according to GlobalData’s Pharma Intelligence Center Deals Database. An IPO occurs when a private company offers its shares to the public and, upon completion, becomes a publicly traded company ...